Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5026
AllianzIM U.S. Equity Buffer15 ETF
QBSF
$59.4M
| $28 | ﹤0.01% |
1
| – | – |
2026 Q1
2 quarters
|
|
5027
LGL Group
LGL
$83.6M
| $27 | ﹤0.01% |
4
-96
| -96% | -$680 |
2026 Q2
1 quarter
|
|
|
DCM
5028
DeFi Capital Markets, Inc.
DCM
$9.02M
| $26 | ﹤0.01% |
+5
| New | +$22 |
2026 Q3
0 quarters
|
|
5029
Global Indemnity Group
GBLI
$318M
| $25 | ﹤0.01% |
1
-8
| -89% | -$218 |
2022 Q1
18 quarters
|
|
5030
Home Federal Bancorp
HFBL
$69.7M
| $25 | ﹤0.01% |
1
| – | – |
2026 Q2
1 quarter
|
|
5031
State Street SPDR Portfolio Aggregate Bond Index ETF
SPAB
$10.4B
| $24 | ﹤0.01% |
1
| – | – |
2024 Q4
7 quarters
|
|
5032
Transact Technologies
TACT
$50.3M
| $24 | ﹤0.01% |
5
-95
| -95% | -$489 |
2026 Q2
1 quarter
|
|
5033
Smartbird Inc
BIRD
$15.5M
| $23 | ﹤0.01% |
+9
| New | +$23 |
2026 Q3
0 quarters
|
|
5034
Dawson Geophysical
DWSN
$50.9M
| $23 | ﹤0.01% |
8
-398
| -98% | -$1.62K |
2026 Q2
1 quarter
|
|
5035
Bolt Biotherapeutics
BOLT
$15.4M
| $22 | ﹤0.01% |
6
| – | – |
2022 Q1
18 quarters
|
|
5036
Neuraxis
NRXS
$78.4M
| $22 | ﹤0.01% |
3
-401
| -99% | -$2.66K |
2026 Q2
1 quarter
|
|
5037
Travelzoo
TZOO
$51.3M
| $22 | ﹤0.01% |
4
-712
| -99% | -$5.5K |
2024 Q3
8 quarters
|
|
5038
Where Food Comes From
WFCF
$76.3M
| $22 | ﹤0.01% |
+2
| New | +$25 |
2026 Q3
0 quarters
|
|
5039
Adicet Bio
ACET
$28.6M
| $21 | ﹤0.01% |
+3
| New | +$26 |
2026 Q3
0 quarters
|
|
5040
TechPrecision Corp
TPCS
$49.7M
| $21 | ﹤0.01% |
4
-38
| -90% | -$196 |
2026 Q2
1 quarter
|
|
5041
BGSF Inc
BGSF
$36.7M
| $20 | ﹤0.01% |
4
-73
| -95% | -$395 |
2026 Q2
1 quarter
|
|
5042
Kyntra Bio
KYNB
$15.1M
| $20 | ﹤0.01% |
+3
| New | +$22 |
2026 Q3
0 quarters
|
|
5043
Filana Therapeutics
FLNA
$21.9M
| $20 | ﹤0.01% |
22
-270
| -92% | -$254 |
2020 Q2
25 quarters
|
|
5044
Vivid Seats
SEAT
$23.5M
| $20 | ﹤0.01% |
5
-716
| -99% | -$4.55K |
2022 Q2
17 quarters
|
|
5045
State Street SPDR Portfolio Long Term Corporate Bond Index ETF
SPLB
$1.19B
| $20 | ﹤0.01% |
1
| – | – |
2024 Q4
7 quarters
|
|
5046
Verde Clean Fuels
VGAS
$21.9M
| $19 | ﹤0.01% |
18
-123
| -87% | -$149 |
2023 Q2
13 quarters
|
|
5047
Verrica Pharmaceuticals
VRCA
$54.8M
| $19 | ﹤0.01% |
4
-60
| -94% | -$313 |
2026 Q2
1 quarter
|
|
5048
Polaryx Therapeutics Inc
PLYX
$89.7M
| $19 | ﹤0.01% |
+9
| New | +$20 |
2026 Q3
0 quarters
|
|
5049
Skillsoft
SKIL
$30.6M
| $18 | ﹤0.01% |
3
-402
| -99% | -$2.8K |
2022 Q1
18 quarters
|
|
5050
Workhorse Group
WKHS
$33.8M
| $18 | ﹤0.01% |
6
+5
| +500% | +$15 |
2024 Q4
7 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.